Navigation Links
Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher
Date:10/22/2009

EDMONTON - A University of Alberta medical researcher being hailed as a world leader in his field will receive a major national award for his pioneering work in the development of a new class of drugs for the treatment of heart failure.

The Canadian Cardiovascular Society is giving its 2009 Young Investigator Award in the basic science category to Dr. Gavin Y. Oudit (pronounced OO-diht), an assistant professor in the Faculty of Medicine & Dentistry's Department of Medicine (Division of Cardiology). The prestigious award is to be presented at the society's awards ceremony on Sunday, Oct. 25, during the Canadian Cardiovascular Congress being held in Edmonton.

Millions of people around the world who have high blood pressure and/or heart failure are treated with a class of drugs called ACE inhibitors. Oudit and his collaborators are working on an alternative drug that wouldn't have the negative side effects that often occur with ACE inhibitors while providing a new type of therapeutic benefit. It could also be a potential therapy for kidney, liver and lung diseases as well as cardiovascular conditions.

Oudit, a clinician-scientist trained at the University of Toronto, moved to Edmonton from Toronto in 2008 to continue his groundbreaking research at the University of Alberta and his clinical practice at Alberta Health Services's Mazankowski Alberta Heart Institute and the University of Alberta Hospital.

The co-chair of the society's award committee said Oudit was their unanimous choice. He has established a "highly innovative and productive research program" that has yielded major discoveries, said Dr. Philippe Pibarot, professor in the Department of Medicine at Laval University.

"The committee has been highly impressed by the translational nature of (Oudit's) program, from fundamental molecular advances in our understanding of ACE2 biology to clinical applications," Pibarot added.

"Dr. Oudit has become a world leader in this exciting new area of research, which is very impressive considering the stage of his career."

Oudit was instrumental in a new discovery about the body system that regulates blood pressure and body fluid levels. He was among a group of researchers who made waves with an article published in the scientific journal Nature in 2002, when they reported they had identified the critical function of a new enzyme called ACE2 (angiotensin-converting enzyme 2) as an essential regulator of heart function.

Oudit is funded by the Alberta Heritage Foundation for Medical Research as a Clinical Investigator, and has received a "grant-in-aid" from the Heart and Stroke Foundation of Alberta. As well, his work has been recognized with a five-year operating grant from the Canadian Institutes of Health Research to study the biochemical and physiological effects of ACE2 in heart disease.

Oudit is the third and latest outstanding young clinician-scientist in the Faculty of Medicine & Dentistry to receive recognition and funding for their work from not just one, but all three, of these major granting agencies:

  • Dr. Ken Butcher, a neurologist, is an authority on hemorrhagic stroke, which occurs when a blood vessel bursts in the brain and bleeds into the surrounding tissue. It leaves 80 per cent of victims dead or disabled. No effective treatment is available at this time. Butcher uses a special CT (computerized tomography) technique to see how people respond to treatments that drastically lower their blood pressure right after a stroke.

  • A pilot study by Dr. Justin Ezekowitz and his research team, published by the European Journal of Heart Failure in 2008, found that one-third of heart-failure patients were sent home from emergency. On the strength of this initial research, the three agencies have awarded him grants and other support so he can lead a larger study that will examine the emergency treatment given to patients with acute heart failure.


'/>"/>

Contact: Lindsay Elleker
lindsay.elleker@ualberta.ca
780-619-1200
University of Alberta Faculty of Medicine & Dentistry
Source:Eurekalert

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows
3. New Canadian study finds drug coated heart stents to be safe:
4. Canadians welcome HPV vaccine -- but not at any price
5. Mayo Clinic Calls for Thorough Review of Canadian Pacifics Acquisition of the Dakota, Minnesota & Eastern Railroad
6. Canadian Pacific and Mayo Clinic Build Understanding and Commit to Ongoing Dialogue
7. Map the Canadian Healthcare IT Market with the New HIMSS Analytics Canadian Database(SM)
8. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
9. Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger
10. Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study
11. Leading Travel Insurance Website Now Offers Mexican Auto Insurance to US and Canadian Travelers Going into Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at global ... is recognized globally as one of the healthiest cereals, XieQingkui, the founder of Seamild, ... move to sow the seed of good karma. Buddhism spirit featuring benevolence and sacrifice ...
(Date:1/21/2017)... Pekin, IL (PRWEB) , ... January 21, 2017 , ... ... disorders. Even when individuals experience the freedom of recovery, they often feel shame for ... abuse and post-traumatic stress disorder (PTSD). In the workshop, “Rising Strong in Life After ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and ... essential oils, announced the company had a successful visit to the 2017 ECRM Diet, ... gives companies that work in the nutritional, sports and health industries a chance to ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out ... announced it attended the January ECRM trade show in Hilton Head, SC. , ... was determined to create a line of products that would elevate her fitness regime. ...
(Date:1/20/2017)... ... ... “The Angel”: a heartwarming and earnest tale of faith and believing in the ... is the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of ... asked of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
(Date:1/19/2017)...  Stealth BioTherapeutics Inc. ( Stealth ), a clinical-stage ... announced new additions to its senior leadership team: ... and Daniel Geffken as interim Chief Financial ... , Pharm.D. has been promoted to Chief Clinical Development ... Doug and Daniel to our management team, as both ...
Breaking Medicine Technology: